COSELA™ (Trilaciclib)
- Medicine Name: Cosela
- Generic Name: Trilacicilib
- Dosage Form & Strength: Injection: 300 mg
- Manufactured By: G1 Therapeutics, Inc.
- Administration of Trilacicilib can be responsible for causing injection-site reactions including phlebitis and thrombophlebitis. Assess patients for signs/symptoms of injection-site reactions, phlebitis, and thrombophlebitis, including infusion-site pain and erythema during infusion.
- Administration of Trilacicilib 300 mg injection can cause acute drug hypersensitivity reactions, including facial edema and urticaria. Evaluate patients for signs/symptoms of acute drug hypersensitivity reactions including eye, facial, and tongue edema, pruritus, urticaria, and anaphylactic reactions.
- Serious, life-threatening, or fatal interstitial lung disease (ILD) and/or pneumonitis can emerge in patients treated with cyclin-dependent kinases (CDK)4/6 inhibitors, the same drug class as Trilacicilib.
- Monitor patients for pulmonary symptoms indicative of ILD/pneumonitis such as dyspnea, cough, and hypoxia. For recurrent moderate ILD/pneumonitis, permanently interrupt Trilacicilib. For severe or life-threatening (Grade 4) ILD/pneumonitis, permanently interrupt Trilacicilib.
- Based on its mechanism of action, Cosela 300 mg injection can cause fetal harm if administered to a pregnant woman. Females of reproductive age should use an apt contraception during treatment and for at least three weeks after the final dose.
- Because of the potential for severe adverse reactions in breastfed children, lactating women should not breastfeed while taking treatment with trilacicilib injectable and for at least 3 weeks after the final dose.
What documents are required to import COSELA to India?
COSELA (trilacicilib) injection can be imported by patients or government hospitals only in the name of the patients.
The following documentation is required to import the product:
- Valid prescription from a qualified doctor.
- Patients’ diagnostic reports.
- Patients’ Identity Proof (issued by the government of India).
How does the order confirm?
The order will be confirmed only after the receipt of:
- Valid prescription by healthcare professionals.
- Import permit if applicable.
Is COSELA available in India?
COSELA (trilacicilib injection) is a (prescription drug, prescription medication, or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.
Urgent Meds helps import cancer medicines on the named patient supply (NPS). Urgent Meds is the facilitator providing input
- On the availability of Cosela injection in India (Delhi, Mumbai, Kolkata, Hyderabad, Ahmedabad, Pune, Chennai, and Bangalore etc.).
- Medicine Price.
- Finding Genuine and reliable sources from Canada, Europe, USA, and Australia.
- Ensuring 100% transparency.
COSELA can be made available to patients, doctors, and hospitals in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, Pune, and other cities in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and an import permit.
Urgent Meds can facilitate the supply of COSELA (prescription medicines) to all locations in the world and in India after fulfilling the legal requirement (if applicable).
Please contact +1-647-818-4196 or write to us at info@urgentmeds.in for Cosela injection price in India.
We guarantee quality and delivery anywhere in the world as per the buyer’s requirements
Urgent Meds is proficient in sourcing COSELA (Cancer Treatment Medicines) from around the world and has the capability to supply it. We offer global access to the best available treatment for our customers worldwide.
Urgent Meds is committed to dispensing any valid prescription promptly. All prescriptions are dispensed and verified by registered pharmacists and are dispatched only to the patient’s address from New Delhi, India. Your health and well-being are our top priorities.
What is the Generic Name for the trade name drug Cosela®?
Trilacicilib is the Generic Name for the trade name drug Cosela®.
What is the Manufacturer Name of Cosela®?
Cosela® is manufactured by G1 Therapeutics, Inc.
Is Cosela® approved by the FDA?
Yes, Cosela® is approved by the FDA. Date of approval: February 12, 2021.
What is Cosela®?
Cosela® is a cyclin-dependent kinase 4/6 (CDK4/6) inhibitor myelopreservation therapy for use in patients with SCLC who are receiving chemotherapy.
What is the dosage and form of Cosela® supplied?
Cosela® is supplied for injection: 300 mg of trilaciclib as a lyophilized cake in a single-dose vial for intravenous administration.
What are the most common side effects due to Cosela®?
Most common side effects due to Cosela® include: fatigue, hypokalemia, hypocalcemia, hypophosphatemia, aspartate aminotransferase increased, headache, and pneumonia.
How much does Cosela® cost in India?
Cosela cost in India is reasonable. In order to procure this small cell lung cancer medication authentically, you can call or WhatsApp +1-647-818-4196 or send mail to info@urgentmeds.in.
What are the storage conditions of Cosela®?
Store the vials of Cosela at 20°C to 25°C (68°F to 77°F); excursions are permitted to 15°C to 30°C (59°F to 86°F). The vial stopper is not made with natural rubber latex.
Is it safe to buy Cosela® online from India?
Yes, you can buy Cosela online from India at the best price from Urgent Meds if Cosela® has not been approved or is not available in your country.
Contact Patient Support
If you have any questions or need any help, contact our Patient Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
Disclaimer
All Trademarks and Brands that appear on the website belong to their respective owners and indianpharmanetwork does not lay any claim on them we only provide Information.